Valeant Pharmaceuticals International, Inc. is a multinational, specialty pharmaceutical and medical device company anchored by a collection of world-class franchises and 22,000 employees worldwide who come to work each day with a common goal of improving people’s lives through Valeant’s healthcare products.

Valeant develops, manufactures and markets a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices, which are marketed directly or indirectly in more than 100 countries.

Along with its strong and durable businesses, Valeant is also focused on developing and introducing new treatments. Valeant believes innovation should be judged by the new products and innovation that a company brings to market. Valeant’s R&D outputs make it a leader in the industry.

Valeant’s corporate headquarters are in Laval, Quebec, with U.S. headquarters in Bridgewater, N.J.